D
Revolution Medicines, Inc. RVMD
$37.01 $0.531.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue 19.13M 205.75M 188.10M 151.75M 12.78M
Gross Profit -19.13M -205.75M -188.10M -151.75M -12.78M
SG&A Expenses 40.58M 35.01M 28.21M 23.96M 21.71M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 264.71M 240.76M 216.31M 175.71M 156.64M
Operating Income -264.71M -240.76M -216.31M -175.71M -156.64M
Income Before Tax -247.79M -213.42M -195.32M -156.29M -133.23M
Income Tax Expenses -- -- -753.00K -- --
Earnings from Continuing Operations -247.79M -213.42M -194.57M -156.29M -133.23M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -247.79M -213.42M -194.57M -156.29M -133.23M
EBIT -264.71M -240.76M -216.31M -175.71M -156.64M
EBITDA -262.89M -239.10M -214.61M -174.10M -154.93M
EPS Basic -1.31 -1.13 -1.12 -0.94 -0.81
Normalized Basic EPS -0.82 -0.71 -0.70 -0.59 -0.50
EPS Diluted -1.31 -1.13 -1.12 -0.94 -0.81
Normalized Diluted EPS -0.82 -0.71 -0.70 -0.59 -0.50
Average Basic Shares Outstanding 188.58M 188.15M 173.76M 166.84M 165.14M
Average Diluted Shares Outstanding 188.58M 188.15M 173.76M 166.84M 165.14M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --